← Leaderboards
Kaiyi Li
Baylor College Of Medicine
$3,229,176
Attributed
$3,229,176
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $530K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$3,229,176 · 4
By mechanism
R01$2,551,835 · 2
R21$677,341 · 2
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Daryl A Scott$5,009,303
- Margaret J Wat$155,388
- David B. Roth$10,563,237
- Brendan Hl Lee$62,781,623
- Alan R Davis$2,461,294
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseIn VitroMouse ModelTumorLeadCodeIn VivoMalignant NeoplasmsSpecificityTumor SuppressionPathway InteractionsCellsGenome StabilityBrca2 GeneHomologous RecombinationBrca1 GeneGenetic TranscriptionIncidenceInhibitor/AntagonistDna RepairBinding ProteinsDna SequenceBiometryChromatin
Grant awards (13)
Characterization and targeting BRIT1 deficiency in breast cancer$324,738
R01 · FY2015 · CA · contact PI
Characterization and targeting BRIT1 deficiency in breast cancer$314,996
R01 · FY2014 · CA · contact PI
Characterization and targeting BRIT1 deficiency in breast cancer$305,254
R01 · FY2013 · CA · contact PI
Characterization and targeting BRIT1 deficiency in breast cancer$324,738
R01 · FY2012 · CA · contact PI
BRIT1, A NOVEL HEPATOCELLULAR CARCINOMA TUMOR SUPPRESSOR$171,064
R21 · FY2012 · CA · contact PI
Characterization and targeting BRIT1 deficiency in breast cancer$324,738
R01 · FY2011 · CA · contact PI
BRIT1, A NOVEL HEPATOCELLULAR CARCINOMA TUMOR SUPPRESSOR$205,277
R21 · FY2011 · CA · contact PI
RNAi-Based Therapy of Hepatocellular Carcinoma$224,720
R01 · FY2008 · CA · contact PI
RNAi-Based Therapy of Hepatocellular Carcinoma$224,720
R01 · FY2007 · CA · contact PI
RNAi-Based Therapy of Hepatocellular Carcinoma$231,431
R01 · FY2006 · CA · contact PI
RNAi-Based Therapy of Hepatocellular Carcinoma$276,500
R01 · FY2005 · CA
THE ROLE OF hCdc4 IN HEPATOCELLULAR CARCINOMA$150,500
R21 · FY2004 · DK
THE ROLE OF hCdc4 IN HEPATOCELLULAR CARCINOMA$150,500
R21 · FY2003 · DK